Synthetic prototissue capable of synchronized beatingAllbiopro2018-10-21T12:27:42+09:0010월 21st, 2018|
Merck sells its Flow Cytometry unit for €62.5 millionAllbiopro2018-10-21T12:26:48+09:0010월 21st, 2018|
FDA Promotes Complex Generics and Combination ProductsAllbiopro2018-10-21T12:25:55+09:0010월 21st, 2018|
AbbVie, Morphic Therapeutic Join Forces for Fibrotic Disease TreatmentsAllbiopro2018-10-21T12:25:27+09:0010월 21st, 2018|
Updated: BioSpace’s List of Q4 2018 Life Sciences IPOsAllbiopro2018-10-19T09:33:07+09:0010월 19th, 2018|
Job Market Etiquette: 7 Things Every Successful Job Seeker DoesAllbiopro2018-10-19T09:32:41+09:0010월 19th, 2018|
Engineered Cartilage Provides Relief for Some Osteoarthritis PatientsAllbiopro2018-10-19T09:32:15+09:0010월 19th, 2018|
Two Researchers Tied to Development of Biogen’s Spinraza to Share $3M Breakthrough PrizeAllbiopro2018-10-19T09:31:48+09:0010월 19th, 2018|
Amidst Strong Quarterly Growth, Novartis Receives FDA Complete Response Letter for CanakinumabAllbiopro2018-10-19T09:31:21+09:0010월 19th, 2018|
Immune Design Abandons Cancer Vaccine Program, Drops 20% of Workforce at Two U.S. LocationsAllbiopro2018-10-19T09:30:54+09:0010월 19th, 2018|
NEJM Retracts Another Article Associated With Piero Anversa, Investigates Two MoreAllbiopro2018-10-19T09:30:27+09:0010월 19th, 2018|
AbbVie Invests $100 Million in Morphic Therapeutics to Develop Integrin Inhibitors for Fibrotic DiseasesAllbiopro2018-10-19T09:30:00+09:0010월 19th, 2018|
New Research May Totally Turn Our Understanding of Dementia on Its HeadAllbiopro2018-10-19T09:29:33+09:0010월 19th, 2018|
